Soapbox presentation at CRS discusses uses of EVA copolymer foamed
excipients
Celanese Corporation (NYSE: CE), a global technology and specialty
materials company, will discuss the use of ethylene vinyl acetate (EVA)
as a foamed excipient in controlled release biologic applications at the
2015 Controlled Release Society (CRS) Annual Meeting and Exposition July
26-29 in Edinburgh, Scotland.
Pharmaceutical researchers and manufacturers choose Celanese’s
VitalDose® EVA product over next best alternatives because of its
customizable release properties and ability to blend well with other
polymers. Celanese’s controlled release EVA copolymers have been used in
a wide range of pharmaceutical drug delivery applications, including
transdermal, subcutaneous, ocular, intravaginal, buccal, intraoral, and
rectal.
“EVA excipients are known to provide excellent controlled release
properties for drug dosage forms for both conventional and biologic
APIs. Our EVA excipient, VitalDose®, has been a proven and effective
solution for many years,” said Christian Schneider, R&D laboratory
manager at Celanese. “Now, Celanese brings the unique value proposition
of foamed EVA excipients, an innovative dosage form that would be suited
to advanced APIs, such as Class II and IV small molecules, biologics,
growth factors and stem cells.”
Highlighting the company’s presence at CRS will be a presentation from
Celanese product R&D laboratory manager Christian Schneider who will
discuss the use of EVA in biologics during a soapbox presentation:
Title: “Foamed Polymer Excipients: Novel Way to Deliver Stem
Cells, Growth Factors, and Biologics for Controlled Release Applications”
Date:
Sunday, July 26, 2015 at 1:25 p.m.
Presenter: Christian
Schneider, R&D Laboratory, Celanese
Celanese will exhibit its customizable controlled release pharmaceutical
copolymer, VitalDose®, at booth number 604.
For more product information, please access these resources:
About Celanese
Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications. With sales almost
equally divided between North America, Europe and Asia, the company uses
the full breadth of its global chemistry, technology and business
expertise to create value for customers and the corporation. Celanese
partners with customers to solve their most critical needs while making
a positive impact on its communities and the world. Based in Dallas,
Texas, Celanese employs approximately 7,500 employees worldwide and had
2014 net sales of $6.8 billion. For more information about Celanese
Corporation and its product offerings, visit www.celanese.com
or our blog at www.celaneseblog.com.
All registered trademarks are owned by Celanese International
Corporation or its affiliates.
Forward-Looking Statements
This release may contain “forward-looking statements,” which include
information concerning the company’s plans, objectives, goals,
strategies, future revenues or performance, capital expenditures,
financing needs and other information that is not historical
information. When used in this release, the words “outlook,” “forecast,”
“estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,”
“believes,” and variations of such words or similar expressions are
intended to identify forward-looking statements. All forward-looking
statements are based upon current expectations and beliefs and various
assumptions. There can be no assurance that the company or customers
will realize these expectations or that these beliefs will prove
correct. There are a number of risks and uncertainties that could cause
actual results to differ materially from the forward-looking statements
contained in this release. Numerous factors, many of which are beyond
the company’s control, could cause actual results to differ materially
from those expressed as forward-looking statements. Other risk factors
include those that are discussed in the company’s filings with the
Securities and Exchange Commission. Any forward-looking statement speaks
only as of the date on which it is made, and the company undertakes no
obligation to update any forward-looking statements to reflect events or
circumstances after the date on which it is made or to reflect the
occurrence of anticipated or unanticipated events or circumstances.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150723005390/en/
Copyright Business Wire 2015